Shefaa AlAsfoor

发表

Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver

T. Rohm, C. Cavelti-Weder, D. Calabrese, 2018, Scientific Reports.

Pharmacological Macrophage Attenuation by Imatinib Reverts Hepatic Steatosis and Inflammation in Obese Mice

T. Rohm, C. Cavelti-Weder, D. Calabrese, 2017, bioRxiv.

Targeting colonic macrophages improves glycemic control in high-fat diet-induced obesity

P. Hruz, C. Cavelti-Weder, B. Yilmaz, 2022, Communications Biology.

Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver

C. Cavelti-Weder, D. Calabrese, A. Weber, 2018, Scientific Reports.

Air pollution mediates diabetes by disrupting gut innate mucosal immunity

C. Cavelti-Weder, Marcin Stawiski, S. Mitrović, 2019, bioRxiv.

Lung versus gut exposure to air pollution particles differentially affect metabolic health in mice

C. Cavelti-Weder, Marcin Stawiski, S. Mitrović, 2023, Particle and Fibre Toxicology.

Diesel Exhaust Particle (DEP)-induced glucose intolerance is driven by an intestinal innate immune response and NLRP3 activation in mice

C. Cavelti-Weder, Julien Roux, D. T. Meier, 2023, Particle and Fibre Toxicology.

Roux-en-Y gastric bypass with a long versus a short biliopancreatic limb improves weight loss and glycemic control in obese mice.

S. Häfliger, R. Schneider, M. Kraljević, 2022, Surgery for Obesity and Related Diseases.

Adeno‐associated virus‐9 reverses delayed gastric emptying of solids in diabetic mice

Matthew L. Hillestad, G. Farrugia, M. Grover, 2023, Neurogastroenterology and motility.